Skip to main content
SpringerLink
Log in

Neue Studien mit Antiarrhythmika zur Verbesserung der Prognose von Patienten nach Myokardinfarkt

  • Conference paper
Medikamentöse Behandlung des Postinfarktpatienten nach CAST

  • 20 Accesses

Zusammenfassung

Der plötzliche Herztod ist die wichtigste Todesursache von Patienten nach Myokardinfarkt. Meist ist er die Folge von schweren ventrikulären Rhythmusstörungen bzw. Kammerflimmern (7). Mehrere Studien haben gezeigt, daß persistierende, komplexe ventrikuläre Rhythmusstörungen nach Infarkt eine wichtige Voraussage über das Eintreten des plötzlichen Herztodes zulassen, und zwar unabhängig vom Vorhandensein oder Fehlen einer eingeschränkten Pumpfunktion (5,9,10). Deshalb wurden verschiedene Versuche unternommen, die Mortalität nach Infarkt durch medikamentöse Unterdrückung der ventrikulären Rhythmusstörungen zu vermindern.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Burckhardt D, Robertson A, Hoffmann A, Pfisterer M (1991) Long-term treatment of ventricular with amiodarone in presence of severe left ventricular dysfunction. J Clin Pharmacol (in press)

    Google Scholar 

  2. Burkart F, Pfisterer M, Kiowski W, Follath F, Burckhardt D (1990) Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias. J Am Coll Cardiol 16: 1711–1718

    Article  PubMed  CAS  Google Scholar 

  3. Cairns JA, Connolly SJ, Gent M, Roberts RS (1990) Canadian amiodarone myocardial infarction arrhythmia trial ( CAMIAT) pilot results (abstr ). Circulation 82–111: 139

    Google Scholar 

  4. Cardiac Arrhythmia Suppression Trial (1989) Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. J Engl J Med 321: 406–412

    Article  Google Scholar 

  5. The Coronary Drug Project Research Group (1973) Prognostic importance of premature beats following myocardial infarction. JAMA 223: 1116–1124

    Article  Google Scholar 

  6. Dargie HJ, Cleland JGF, Leckie BJ, Inglis CG, East BW, Ford I (1987) Relation of arrhythmias and electrolyte abnormalities to survival in patients with severe chronic heart failure. Circulation 75 ( Suppl IV ): IV 98–107

    Google Scholar 

  7. Kannel WB, Cupples LA, D’Agostino RBJ (1987) Sudden death risk in overt coronary heart disease: the Framingham study. Am Heart J 113: 799–804

    Article  PubMed  CAS  Google Scholar 

  8. Kaski JC, Girotti LA, Messuti H, Rutitzky B, Rosenbaum MB (1981) Long-term management of sustained, recurrent, symptomatic ventricular tachycardia with amiodarone. Circulation 64: 273–279

    Article  PubMed  CAS  Google Scholar 

  9. Moss AJ, De Camilla JJ, Davis HP, Bayer L (1977) Clinical significance of ventricular ectopic beats in the early posthospital phase of myocardial infarction. Am J Cardiol 39: 635–640

    Article  PubMed  CAS  Google Scholar 

  10. The Multicenter Postinfarction Research Group (1983) Risk Stratification and Survival after Myocardial Infarction. N Eng J Med 309: 331–336

    Article  Google Scholar 

  11. Pfisterer M, Burkart F, Müller-Brand J, Kiowski W (1985) Important differences between shortand long-term hemodynamic effects of amiodarone in patients with chronic ischemic heart disease at rest and during ischemia-induced left ventricular dysfunction. J Am Coll Cardiol 5: 1205–11

    Article  PubMed  CAS  Google Scholar 

  12. Polster P, Broekhuysen J (1976) The adrenergic antagonism of amiodarone. Biochem Pharmacol 25: 131–134

    Article  PubMed  CAS  Google Scholar 

  13. Rostock KJ (1991) Lehren aus der CAST-Studie. In: Rostock KJ, Schmidt G (eds) Medikamentöse Behandlung des Postinfarktpatienten nach CAST, Steinkopff, Darmstadt, In diesem Buch

    Google Scholar 

  14. Ruskin J (1990) Lessons from the CAST trial. American Heart Association annual meeting, Dallas, 1990

    Google Scholar 

  15. Singh BN (1989) Controlling cardiac arrhythmias: to delay conduction or to prolong refractoriness. Cardiovasc Drugs Ther 3: 671–674

    Article  PubMed  CAS  Google Scholar 

  16. Singh B (1990) persönliche Mitteilung. Los Angeles

    Google Scholar 

  17. Teo K, Yusuf S, Furberg C (1990) Effect of antiarrhythmic drug therapy on mortality following myocardial infarction (abstr). Circulation 82–III: 197

    Google Scholar 

  18. Zelvelder WG (1971) Investigation of the therapeutic activity of amiodarone in the treatment of angina pectoris. Eur J Clin Pharmacol 3: 158–162

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abteilung für Kardiologie, Departement Innere Medizin, Basler Universitätskliniken, CH-4031, Basel, Schweiz

    Prof. Dr. med. M. Pfisterer FESC, FACC, F. Burkart, W. Kiowski & D. Burckhardt

Authors
  1. Prof. Dr. med. M. Pfisterer FESC, FACC
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. Burkart
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. W. Kiowski
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. Burckhardt
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. I. Medizinische Klinik, Technischen Universität München Klinikum rechts der Isar, Ismaninger Straße 22, 8000, München 80, Germany

    Georg Schmidt

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Dr. Dietrich Steinkopff Verlag, GmbH & Co. KG, Darmstadt

About this paper

Cite this paper

Pfisterer, M., Burkart, F., Kiowski, W., Burckhardt, D. (1991). Neue Studien mit Antiarrhythmika zur Verbesserung der Prognose von Patienten nach Myokardinfarkt. In: Schmidt, G. (eds) Medikamentöse Behandlung des Postinfarktpatienten nach CAST. Steinkopff. https://doi.org/10.1007/978-3-642-85414-9_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-85414-9_3

  • Publisher Name: Steinkopff

  • Print ISBN: 978-3-642-85415-6

  • Online ISBN: 978-3-642-85414-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation